The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a nonpartisan foundation focused on improving the health of communities and entire populations.
Alan B. Cohen,
This issue of the Quarterly features opinion pieces from several of our contributing writers as well as invited commentaries from noted guest… More
Our Opinion section features some of the best minds currently working to improve the public’s health.
Lawrence O. Gostin,
K. John McConnell,
Gail R. Wilensky,
Paula M. Lantz,
Harold A. Pollack,
Jacob S. Sherkow,
Edward H. Wagner,
This month, The Milbank Quarterly introduces a new series of Milbank Quarterly Classics. These were landmark articles when originally published by the journal over the course of its 97-year history that continue to resonate today with lessons for contemporary policymakers and practitioners. We are first recognizing “Organizing Care for Patients with Chronic Illness,” a 1996 article by Edward Wagner, Brian Austin, and Michael Von Korff that outlined a chronic care model for treating individuals with chronic illnesses. More
Donald M. Berwick,
Donald Berwick, president emeritus and senior fellow at the Institute for Healthcare Improvement, reflects on the chronic care model’s role in health care delivery as the gold standard for managing chronically ill patients. More
Russell E. Glasgow, Amy G. Huebschmann, Alex H. Krist, Frank V. DeGruy, III,
This new research builds upon the chronic care model to create an integrated, patient-directed system that takes greater account of a patient’s life, such as the degree of available support in the home, work, and primary care settings. More
Hector P. Rodriguez, Bing Ying Poon, Emily Wang, Stephen M. Shortell,
Adoption of patient engagement strategies among ACO-affiliated practices did not improve patient-reported outcomes of physical, emotional, and social function among adult patients with diabetes and/or cardiovascular disease over one year, according to this study. More
Courtney D. Cogburn,
As a fundamental cause of health inequalities and disease, racism will require policy solutions that address its role. Such policies should be grounded in social theory and meaningful assessments of the social context concerning race, racism, and health. More
Bård Hobæk, Anne Kveim Lie,
Norway’s “rational,” public health–driven approach to drug regulation can inform new policies for curbing antibiotic resistance, this new analysis finds. More
Audrey D. Zhang, Jason L. Schwartz, Joseph S. Ross,
The FDA disagreed with 22% of its advisory committee recommendations over an 8-year period, according to this original research. In the case of disagreements, the FDA tended to be less likely than its advisory committees to approve new products, approve new supplemental indications, or enact new safety changes. More
Despite loosening its standards for drug approval over time, the US Food and Drug Administration (FDA) is not restructuring itself to properly enforce the ongoing regulation of drugs once they are on the market. Current and former FDA officials interviewed for this study affirmed the FDA also has little legal authority to oversee postmarket studies. More
Brendan Collins, Chris Kypridemos, Jonathan Pearson-Stuttard, Yue Huang, Piotr Bandosz, Parke Wilde, Rogan Kersh, Simon Capewell, Dariush Mozaffarian, Laurie P. Whitsel, Renata Micha, Martin O'Flaherty, on behalf of the Food-PRICE Investigators,
Researchers modeled the health and economic impact of meeting the FDA’s recommended sodium reduction targets on food system workers from 2017 to 2036 for this study. They found the value of health gains and health care cost savings associated with implementing the voluntary sodium targets would outweigh the costs of reformulation for the food industry at large. More
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, political, historical, legal, and ethical dimensions of health and health care policy.